Receive a comprehensive update on new outcomes from clinical trials in Endocrinology and a new understanding of pathogenetic mechanisms.
This unique event provides a full CME program across the spectrum of Diabetes and Endocrinology. In a fast-moving field, it is impossible to keep up with the latest trials and understand how they will affect clinical practice. The yearbook is the answer to this never-ending problem. Experts in the field will review new research and treatments that have excited them most over the past two years.
In addition to the mainstream topics of diabetes, thyroid pathology and pituitary disease, selected specialist topics such as male fertility and Turner Syndrome will be visited by experts in these conditions.
This event is a great opportunity to network with colleagues and take part in an interactive discussion of hot topics.
Meeting topics:
- Treatment combinations in Type 1 diabetes
- New insights into gestational diabetes
- Oestrogen replacements for young women
- Thyroid ultrasound
Early bird pricing available until 23 June 2019.
| RSM Fellow | RSM Associate | RSM Retired Fellow | RSM Trainee | RSM Student |
|---|---|---|---|---|
| £75.00 | £45.00 | £45.00 | £45.00 | £25.00 |
| Consultant / GP | AHP / Nurse / Midwife | Trainee | Student |
|---|---|---|---|
| £125.00 | £75.00 | £45.00 | £42.00 |
Professor of Obstetrics and Gynaecology and Dean of Undergraduate Medicine at Kings College London.
Her areas of special interest are Minimal Access Surgery, Ovarian Failure, Medical Education and Female Genital Mutilation. She is an educational supervisor for specialist trainees and a preceptor for specialist advanced training modules in minimal access surgery, menopause and education. She has published over 100 peer review papers and 15 textbooks.
Professor of Medicine (Diabetes and Antenatal Care) at the University of East Anglia and Professor of Women’s Health at Kings College London.
Helen runs a diabetes pregnancy research programme which aims to improve the glucose control and infant health outcomes of pregnant women with diabetes. Her research interests include improving access to preconception care, developing novel continuous glucose monitoring and artificial pancreas technologies and the role of maternal dietary intake in gestational diabetes. She supervises higher degree students from diabetes & endocrinology, clinical biochemistry and obstetrics & gynaecology. Her research is funded by the National Institute for Health Research (NIHR), Juvenile Diabetes Research Foundation (JDRF), Diabetes UK, Diabetes Research & Wellness Foundation (DRWF), and European Association for the Study of Diabetes (EASD).
Professor David Leslie is consultant physician at St Bartholomew's Hospital and Professor of Diabetes and Autoimmunity at the Blizard Institute, Queen Mary, University of London. He was previously elected President of The Association of Physicians of Great Britain and Ireland.
Professor David Leslie has been Principle Investigator of three major EU programmes (EXALT, BLUEPRINT and Action LADA) and Founding Chairman of T1DUK. His research is based on the use of cutting-edge technology applied to unique cohorts (e.g. twins and adult onset autoimmune diabetes patients) to define the nature and origins of type 1 diabetes
Professor David Leslie, Queen Mary College
Dr Helen Murphy
Professor Anthony Wierzbicki
Dr Umasuthan Srirangalingham, UCLH London
Dr Amir Sam, Imperial College, London
Dr Helen Turner, Oxford
Professor Janice Rymer, King’s College London
Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom
